P1638: EARLY USE OF ELTROMBOPAG IN ADULT PATIENTS WITH ITP WHO ARE REFRACTORY OR RELAPSED AFTER FIRST-LINE CORTICOSTEROID THERAPY – AN AD HOC ANALYSIS OF THE TAPER TRIAL RESULTS

por Ghanima, W., Zaja, F., Maier, J., Haenig, J., Lee, J., Cooper, N.
Publicado 2022

P1697: EVALUATION OF THE DIAGNOSTIC PERFORMANCE OF THE TINA-QUANT D-DIMER GEN. 2 IN PATIENTS WITH SUSPECTED DEEP VEIN THROMBOSIS

por Tonne, B., Pedersen, M. H., Fronas, S. G., Jorgensen, C. T., Mathisen, A.-B., Ghanima, W., Garabet, L.
Publicado 2022

PB2300: COMPLEMENT ACTIVATION NEGATIVELY AFFECTS THE PLATELET RESPONSE TO THROMBOPOIETIN RECEPTOR AGONISTS IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA: A PROSPECTIVE COHORT STUDY

por Åkesson, A., Bussel, J. B., Martin, M., Blom, A. M., Klintman, J., Ghanima, W., Zetterberg, E., Garabet, L.
Publicado 2022

Effects of pulmonary rehabilitation on cardiac magnetic resonance parameters in patients with persistent dyspnea following pulmonary embolism

por Gleditsch, J., Jervan, Ø., Haukeland-Parker, S., Tavoly, M., Geier, O., Holst, R., Klok, F.A., Johannessen, H.H., Ghanima, W., Hopp, E.
Publicado 2022

PB2313: DARATUMUMAB AS A TREATMENT FOR ADULT IMMUNE THROMBOCYTOPENIA: A PHASE II STUDY WITH SAFETY RUN-IN (THE DART STUDY)

por Tsykunova, G., Holme, P. A., Thi Thyuet Tran, H., Tvedt, T. H. A., Munthe, L., Michel, M., Frederiksen, H., Bussel, J., Kuter, D., Ghanima, W.
Publicado 2022

P1684: NO INCREASE IN THROMBIN GENERATION OR D-DIMER LEVELS AFTER ANTI-SARS-COV-2 VACCINES INCLUDING IN THOSE WITH ANTI-PLATELET FACTOR 4 ANTIBODIES

por Garabet, L., Eriksson, A., Tjønnfjord, E., Kringstad Olsen, M., Jacobsen, H. K., Tøvik Jørgensen, C., Mathisen, Å.-B., Mowinckel, M.-C., Ahlen, M. T., Hausberg Sørvoll, I., Daae Horvei, K., Leiknes Ernstsen, S., Jenssen Lægreid, I., Sandset, P. M., Ghanima, W.
Publicado 2022